May 15th, 2022
From the desk of The Editor
Dear Reader,
DividendPress.com have identified several energy stocks which are expected to go “Ex-Dividend” very soon.
If you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment.
Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend.
If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend.
So please keep this in mind.
Below is our latest Dividend Report:
Global Cord Blood
Symbol: CO
Recent Price: $$2.75
Average Analyst Price Target: n/a ({Analyst Price Target - upside/downside})
Market Cap: $$334.27M
Expected Ex-Dividend Date: n/a
Expected Payment Date: n/a
Expected Dividend & Yield:
Recent Analyst Action: n/a n/a, analyst at n/a, reiterates coverage on Global Cord Blood (CO) in the Healthcare sector with a n/a rating and a price target of n/a (n/a).
TipRanks.com also reports that Global Cord Blood currently has n/a analysts offering 12-month price targets and the consensus is a rating with an average price target is n/a . The target pricing ranges from a high forecast of n/a down to a low forecast of n/a. Global Cord Blood (CO)’s last closing price was $$2.75 which would put the average price target at {Analyst Price Target - upside/downside} upside.Here are 3rd party ratings for CO:
Recent Analyst Action: T J, analyst at RBC Capital, reiterates coverage on Marathon Petroleum (MPC) in the Utilities sector with a Buy rating and a price target of $ 108 (1 week ago).
TipRanks.com also reports that Marathon Petroleum currently has 11 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $102.82 . The target pricing ranges from a high forecast of $115.00 down to a low forecast of $85.00. Marathon Petroleum (MPC)’s last closing price was $$95.88 which would put the average price target at {Analyst Price Target - upside/downside} upside.Here are 3rd party ratings for MPC:
Recent Analyst Action: Daniel Arias, analyst at Stifel Nicolaus, reiterates coverage on Mettler-Toledo (MTD) in the Healthcare sector with a Hold rating and a price target of $ 1500 (1 week ago).
TipRanks.com also reports that Mettler-Toledo currently has 5 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $1,359 . The target pricing ranges from a high forecast of $1,500 down to a low forecast of $1,240. Mettler-Toledo (MTD)’s last closing price was $$1,255.11 which would put the average price target at {Analyst Price Target - upside/downside} upside.Here are 3rd party ratings for MTD:
Recent Analyst Action: Shelby Tucker, analyst at RBC Capital, reiterates coverage on Centerpoint Energy (CNP) in the Utilities sector with a Buy rating and a price target of $ 34 (1 week ago).
TipRanks.com also reports that Centerpoint Energy currently has 13 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $33.92 . The target pricing ranges from a high forecast of $36.00 down to a low forecast of $29.00. Centerpoint Energy (CNP)’s last closing price was $$31.03 which would put the average price target at {Analyst Price Target - upside/downside} upside.Here are 3rd party ratings for CNP:
Recent Analyst Action: Kevin Grundy, analyst at Jefferies, reiterates coverage on Church & Dwight (CHD) in the Consumer Goods sector with a Buy rating and a price target of $ 112 (2 weeks ago).
TipRanks.com also reports that Church & Dwight currently has 8 analysts offering 12-month price targets and the consensus is a Moderate Sell rating with an average price target is $92.13 . The target pricing ranges from a high forecast of $112.00 down to a low forecast of $80.00. Church & Dwight (CHD)’s last closing price was $$98.15 which would put the average price target at {Analyst Price Target - upside/downside} upside.Here are 3rd party ratings for CHD:
And there you have it...
Keep in mind, if you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment.
Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend.
If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend.
If you have questions about specific dividends, you should consult with your financial advisor or visit Investor.gov for more information.
Sincerely,
The Editor